DK0916663T3 - 18beta, 19beta-diacetyloxy-18alpha, 19alpha-epoxy-3,13(16), 14-clerodatrien-2-on (Esculentin A) og 18beta, 19beta-diacetyloxy-18alpha, 19alpha-epoxy-3, 12, 14-clerodatrien-2beta-isovaleryloxy-6beta, 7alpha-diol (Esculentin B), fremgangsmåde........ - Google Patents

18beta, 19beta-diacetyloxy-18alpha, 19alpha-epoxy-3,13(16), 14-clerodatrien-2-on (Esculentin A) og 18beta, 19beta-diacetyloxy-18alpha, 19alpha-epoxy-3, 12, 14-clerodatrien-2beta-isovaleryloxy-6beta, 7alpha-diol (Esculentin B), fremgangsmåde........

Info

Publication number
DK0916663T3
DK0916663T3 DK98121657T DK98121657T DK0916663T3 DK 0916663 T3 DK0916663 T3 DK 0916663T3 DK 98121657 T DK98121657 T DK 98121657T DK 98121657 T DK98121657 T DK 98121657T DK 0916663 T3 DK0916663 T3 DK 0916663T3
Authority
DK
Denmark
Prior art keywords
esculentin
diacetyloxy
epoxy
19beta
18alpha
Prior art date
Application number
DK98121657T
Other languages
Danish (da)
English (en)
Inventor
Swati Dr Bal-Tembe
Kumar Erra Koteswara Sa Vijaya
Deore Vijay Dipex-Kira Bhagwan
Joshi Kalpana Dr Sanjay
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK0916663T3 publication Critical patent/DK0916663T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Furan Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Steroid Compounds (AREA)
DK98121657T 1997-11-18 1998-11-12 18beta, 19beta-diacetyloxy-18alpha, 19alpha-epoxy-3,13(16), 14-clerodatrien-2-on (Esculentin A) og 18beta, 19beta-diacetyloxy-18alpha, 19alpha-epoxy-3, 12, 14-clerodatrien-2beta-isovaleryloxy-6beta, 7alpha-diol (Esculentin B), fremgangsmåde........ DK0916663T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97120143 1997-11-18

Publications (1)

Publication Number Publication Date
DK0916663T3 true DK0916663T3 (da) 2003-07-28

Family

ID=8227636

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98121657T DK0916663T3 (da) 1997-11-18 1998-11-12 18beta, 19beta-diacetyloxy-18alpha, 19alpha-epoxy-3,13(16), 14-clerodatrien-2-on (Esculentin A) og 18beta, 19beta-diacetyloxy-18alpha, 19alpha-epoxy-3, 12, 14-clerodatrien-2beta-isovaleryloxy-6beta, 7alpha-diol (Esculentin B), fremgangsmåde........

Country Status (8)

Country Link
US (1) US6107335A (pt)
EP (1) EP0916663B1 (pt)
JP (1) JP4373510B2 (pt)
AT (1) ATE239715T1 (pt)
DE (1) DE69814307T2 (pt)
DK (1) DK0916663T3 (pt)
ES (1) ES2198631T3 (pt)
PT (1) PT916663E (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007001331A (es) * 2004-08-04 2008-03-11 Foam Supplies Inc Variacion de la reactividad y degradacion del catalizador en espuma de poliuretano.
CN104418829A (zh) * 2013-09-07 2015-03-18 山东大学(威海) 一种具有抗肿瘤作用的化合物单叶蔓荆素b的结构与制备方法及其用途
CN112239439A (zh) * 2019-07-17 2021-01-19 南开大学 四种具有抗癌活性的烈味脚骨脆二萜的制备方法和用途
IT201900018938A1 (it) 2019-10-16 2021-04-16 Univ Degli Studi Roma La Sapienza Uso di esculentina e suoi derivati per uso per il trattamento della fibrosi cistica

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468772A (en) * 1993-03-10 1995-11-21 Pharmagenesis, Inc. Tripterinin compound and method

Also Published As

Publication number Publication date
US6107335A (en) 2000-08-22
ES2198631T3 (es) 2004-02-01
JPH11236383A (ja) 1999-08-31
EP0916663B1 (en) 2003-05-07
ATE239715T1 (de) 2003-05-15
DE69814307T2 (de) 2004-07-01
PT916663E (pt) 2003-09-30
DE69814307D1 (de) 2003-06-12
EP0916663A1 (en) 1999-05-19
JP4373510B2 (ja) 2009-11-25

Similar Documents

Publication Publication Date Title
DK15589A (da) Kemiske forbindelser
IL89835A0 (en) Substituted azetidinones,their preparation and pharmaceutical compositions containing them
ATA195588A (de) Epipodophyllotoxinglucosid-4'-phosphat-derivate deren herstellung, sowie pharmazeutische zusammensetzungen hierzu
DE3769174D1 (de) Indolizin-derivate, verfahren zur herstellung und diese enthaltende zusammensetzungen.
MX9602806A (es) Derivados del 1,2,4-oxadiazol y su uso como parasiticidas para animales.
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
FR2703051B1 (fr) Nouvelles pyridothiadiazines, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
FI903759A0 (fi) Farmaceutisk komposition innehaollande n-acetylcystein foer oral administrering.
NO303783B1 (no) Substituerte aminofosfonatderivater og farmas°ytiske preparater derav
DK0400522T3 (da) Fremgangsmåde til fremstilling af mikroniserede bionedbrydelige partikler
DE59300176D1 (de) 5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen.
ES2127181T3 (es) 11-beta-aril-gona-4,9-dien-3-onas.
NO20010940D0 (no) TAN-1057 derivater
IT1238414B (it) Impianto e procedimento per la formatura di elastomeri.
DK0916663T3 (da) 18beta, 19beta-diacetyloxy-18alpha, 19alpha-epoxy-3,13(16), 14-clerodatrien-2-on (Esculentin A) og 18beta, 19beta-diacetyloxy-18alpha, 19alpha-epoxy-3, 12, 14-clerodatrien-2beta-isovaleryloxy-6beta, 7alpha-diol (Esculentin B), fremgangsmåde........
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
DE3578597D1 (de) 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
FI903701A0 (fi) Reninhaemmande amino-oligohydroxiderivat.
KR950703559A (ko) 신규한 축합 티아졸 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물(Novel condensed thiazole derivative, process for producing the same, and pharmaceutical composition containing the same)
DE59003446D1 (de) 13-Brom und 13, 14-Dibrom-Ergoline, ihre Herstellung und Verwendung in Arzneimitteln.
DE59003003D1 (de) Anlage zur herstellung von malz aus getreide.
DE3888697D1 (de) 2,3-thiomorpholinedion-2-oxim-derivate, arzneimittelzusammensetzungen und verfahren zur herstellung.
DE69501660D1 (de) Neue 17-(3-Imino-2-alkyl-propenyl)-5beta-14beta-Androstanderivate, zur Behandlung von kardiovaskulären Erkrankungen, ein Verfahren zu ihrer Herstellung und pharmazeutische Präparate davon
PT88578A (pt) Process for the manufacture of 2,6-methanopyrrolo-3-benzazocines of intermediates useful for their manufacture and of pharmaceutical compositions containing them
IT8648800A0 (it) Derivati benzofenonici,utili come agenti antisolari ad elevata sostantivita',loro procedimento di produzione e composizioni cosmetiche cheli contengono